This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is not true, under UCC Article 2, about a merchant's firm offer: a. requires ... (Read 144 times)

ishan

  • Hero Member
  • *****
  • Posts: 546
Which of the following is not true, under UCC Article 2, about a merchant's firm offer:
 a. requires a signed writing by the offeror that the offer will remain open for a given period b. it must be open to all members of the public
  c. stays open for a time not to exceed 3 months, if no other period of time is stated in the offer d. does not require consideration to be irrevocable
  e. is irrevocable if stated in writing that it remains open for a given time

Question 2

Which of the following is true of a trade secret:
 a. the business would lose its advantage if the competition were to obtain it b. it is copyrighted
  c. the owner has not taken reasonable steps to protect the secret from disclosure d. all of the other specific choices are correct
  e. none of the other specific choices are correct



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

cegalasso

  • Sr. Member
  • ****
  • Posts: 295
Answer to Question 1

b

Answer to Question 2

a





 

Did you know?

When taking monoamine oxidase inhibitors, people should avoid a variety of foods, which include alcoholic beverages, bean curd, broad (fava) bean pods, cheese, fish, ginseng, protein extracts, meat, sauerkraut, shrimp paste, soups, and yeast.

Did you know?

One way to reduce acid reflux is to lose two or three pounds. Most people lose weight in the belly area first when they increase exercise, meaning that heartburn can be reduced quickly by this method.

Did you know?

During the twentieth century, a variant of the metric system was used in Russia and France in which the base unit of mass was the tonne. Instead of kilograms, this system used millitonnes (mt).

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

For a complete list of videos, visit our video library